Emerging Growth for Menopause Treatment Market by 2021-2027

1. Global Menopause Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027. Changing lifestyle and increasing awareness among middle aged women are key driving factors for the growth of Global Menopause Treatment Market. Global Menopause Treatment Market is valued at USD 2406.0 Million in 2017 and expected to reach USD 3049.97 Million by 2027 with a CAGR of 2.4% over the forecast period. Get Sample Copy of The Report@ https://brandessenceresearch.com/requestSample/PostId/1455 Scope of Global Menopause Treatment Market Report: Menopause is a natural process which marks the end of menstrual cycles and it is also known as Climacteric. It can also be associated by decrease in estrogen and progesterone levels. The typical age for experiencing menopause is 45 – 55 years and varies individually. Some women will find it difficult while going through this stage; symptoms include weight gain, hot flashes, and vaginal dryness. These symptoms continue for around 4 years after last period and for 12 years for around 10% of women. Menopause requires treatment for relieving the signs and preventing the chronic conditions related to it or occurs due to aging. In order to curb these symptoms there is a growing demand in medication and technology which can be the key benefits in menopause treatment market. Key Players for Global Menopause Treatment Market Report: Some major key players for Global Menopause Treatment Market are Fervent Pharmaceuticals, Pfizer, Merck, Novartis, Novo Nordisk, Cipla, Emcure Pharmaceuticals, Allergen plc, Teva Pharmaceuticals and others. North America is dominating the Global Menopause Treatment Market North America is expected to dominate the Global Menopause Treatment Market within the forecast period attributed to the presence of developed healthcare infrastructure and supportive government initiatives for women’s health. Moreover, surge in female population with menopause symptoms are also likely to raise the demand for treatment. According to the study published

2. in journal of The North America Menopause Society (NAMS) the symptoms of menopause is correlated with job environment which affects the working women aged between 45 to 65 years. These symptoms affect them physically, psychologically and sexually. Furthermore, growth in R&D investment and development of novel treatment options are also expected to enhance the market growth. Global Menopause Treatment Market Segmentation: By Non-Hormonal Treatment: Progesterone Estrogen Combination By Hormonal Treatment: Anti-Migraine Anti-Depressants Anti-Anxiety By Distribution Channel: Retail Pharmacies Online Pharmacies Hospital Pharmacies Get Full Report :@ https://brandessenceresearch.com/healthcare/menopause- treatment-market